Beijing State owned Assets Supervision and Administration Corporation listed 33% equity of UBS Securities
芊芊551
发表于 2024-12-7 14:38:57
156
0
0
On November 26th, the Beijing Property Rights Exchange disclosed information that Beijing State owned Assets Management Co., Ltd. (hereinafter referred to as "Beijing State owned Assets") held 33% of the equity of UBS Securities at a transfer price of 1.537 billion yuan.
The disclosure period of this announcement is from November 26th to December 23rd. At present, UBS Securities has two shareholders, UBS AG and Beijing State owned Assets, with shareholding ratios of 67% and 33% respectively. This also means that Beijing State owned Assets intends to sell all of its equity in UBS Securities.
UBS responded to reporters by saying, "UBS increased its stake in UBS Securities to 67% in 2022. As previously disclosed, the process of further increasing its stake in UBS Securities to 100% is underway
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Beijing Lianjia Anxin Service Commitment: Newly Upgraded to Improve Owners' House Selling Experience
- Qualcomm's interest in acquiring Intel reportedly cooled down or considering equity deal
- Porsche's acquisition of Valta equity has been unconditionally approved by the State Administration for Market Regulation
- Alibaba plans to sell 100% equity of Intime to Yagor Group and others for 7.4 billion yuan, with an expected loss of approximately 9.3 billion yuan
- Alibaba sells equity in Intime for 7.4 billion yuan
- Alibaba loses 9.3 billion yuan, sells 100% equity of Intime, Youngor invests in another city
- Sanofi will acquire the exclusive rights of Jixing Pharmaceutical to develop and commercialize Aficamten in Greater China
- Beike: Terminate the acquisition of all remaining equity of Space Intelligence, a home decoration service provider
- Beike: Terminate the acquisition of all remaining equity in Space Intelligence
- Beike terminates acquisition of all remaining equity of Love Space's parent company